Granard House, Fulham Road, London, SW3 6JJTel: 020 7811 8111Email: email@example.com
Recognised as a world-leading centre for treatment and research into cancer, The Royal Marsden has two hospitals, one in Chelsea, Central London, and the other in Sutton, Surrey. The hospital in Chelsea has a dedicated private wing with 21 en-suite private rooms and a comfortable Medical Day Unit enabling patients to have their chemotherapy treatment in a calming environment, without the need to stay overnight in hospital. The inpatient facilities in Sutton are designed to offer privacy in relaxing surroundings. Both sites provide the most up-to-date cancer care from leading cancer specialists as well as offering cutting edge technology to continue to improve cancer treatment.
“As a world-renowned centre of expertise, our vision is to contribute to global improvement in the effective treatment of cancer while providing treatment and care of the highest quality.”
The Royal Marsden is at the forefront in the development and use of new radiotherapy, chemotherapy and surgical techniques for the treatment of cancer:
MR Linac - This machine shows magnetic resonance images and delivers X-ray radiation beams at the same time, allowing radiotherapy to be adjusted and delivered more accurately and effectively than ever before. The Royal Marsden was the first hospital in the UK to use it.
CyberKnife - A robotic radiosurgery system that can destroy inoperable or surgically complex tumours with targeted, high dose radiation.
Intensity modulated radiation therapy (IMRT) - A specialised radiotherapy technique that shapes the radiotherapy beam to the tumour, reducing damage to surrounding tissues and allowing higher doses to be used.
Volumetric modulated arc therapy (VMAT) - An advanced IMRT technique that reduces even further the risk of damage to surrounding tissues and involves shorter treatment times. The Royal Marsden as the first hospital in the UK to use VMAT.
da Vinci robotic surgery systems - The Royal Marsden was the first hospital in the UK to introduce the da Vinci S robotic surgical system back in 2007. The robot allows surgeons to perform minimally invasive surgical techniques for treating prostate cancer. The Royal Marsden has also become the first hospital in England to get the latest version of the robotic surgical system, the da Vinci Xi in 2015. This piece of innovative piece of machinery allows robotic surgeons to operate on other areas of the body and train surgeons of the future.
Neo-adjuvant chemotherapy - The Royal Marsden are pioneers and experts in the use of chemotherapy to shrink breast tumours prior to surgery
Critical Care Unit - This 19 bed unit is the only one of its type in the UK, with two rooms designed for teenagers and young adults offering the highest standard of care.
Oak Centre for Children and Young People - The Oak Centre for Children and Young People is one of the largest comprehensive children and young people’s cancer centres in Europe. It was opened in September 2011 by the President of The Royal Marsden, HRH The Duke of Cambridge, with his wife, HRH The Duchess of Cambridge.
Utilising the latest technology, The Royal Marsden uses pioneering techniques to provide patients with new advanced tailored treatments to help beat cancer. The hospital has the largest drug centre in Europe and ensures that patients receive the best cancer care in a comfortable, modern environment. The Royal Marsden is the only UK centre to be a dedicated NIHR Biomedical Research Centre for cancer meaning patients have faster access to the latest drugs, treatments and clinical trials that are not available anywhere else in the world.
What sets The Royal Marsden apart is the world leading experts. The hospital works with 2,500 of the best cancer specialists including; surgeons, pharmacists and rehabilitation therapists who are dedicated in proving support to all their patients. Our consultants have experience covering some of the rarest and most complex cases.
There are many ways for patients to pay for their treatment at The Royal Marsden, including self pay, private medically insured, or sponsored patients. All patients seeking private cancer treatment at The Royal Marsden, whether insured or self-funding require a referral from a GP or specialist.
The Royal Marsden welcomes patients who wish to fund their own treatment. An estimate of costs can be obtained directly from the hospital and payment is administrated by the Private Care Accounts Office. Deposits are required in advance of any treatment and any consultations and treatments will start after all funds have been cleared. Self paying patients can use the following methods to pay for their treatment:
Patients with private medical insurance are advised to contact The Royal Marsden initially to confirm that the particular insurer is recognised, and then to check with their company that cover is sufficient to pay for all consultations and treatment. The Private Care Accounts Office at the hospital is happy to help with any insurance queries.
Established in 1997, Private Healthcare UK is the number one place on the web for patients seeking information about private treatment, hospitals, clinics, specialists and health insurance.
Visit www.privatehealthcare.co.uk for more information.